What is the expected growth forecast for the Contrast Agents for MRI market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Contrast Agents for MRI market?

Increasing demand for diagnostic imaging and technological advancements drive the market.

What challenges does the Contrast Agents for MRI market face?

Stringent regulations and high development costs are significant challenges.

Which regions are leading the Contrast Agents for MRI market?

North America and Europe are leading regions due to advanced healthcare infrastructure.

Who are the top companies in the Contrast Agents for MRI market?

Key players include GE Healthcare, Bayer, and Bracco Diagnostics.

What future opportunities exist in the Contrast Agents for MRI market?

Emerging economies and growing demand for non-invasive diagnostics offer opportunities.

How does technology impact the Contrast Agents for MRI market?

Advances in MRI technology and contrast agent development improve diagnostic accuracy.

What is the current regulatory landscape for Contrast Agents for MRI?

Regulations vary by region, with the FDA and EMA setting strict guidelines.

What is the future outlook for the Contrast Agents for MRI market?

The market is expected to grow due to increasing diagnostic imaging demand.

Contrast Agents for Magnetic Resonance Imaging (MRI) Market Report 2026: Analyst-Verified Data & Forecast

Contrast Agents for Magnetic Resonance Imaging (MRI) by Application (Radiology, Interventional Radiology, Interventional Cardiology), by Types (Barium-based Contrast Media, Iodinated Contrast Media, Gadolinium-based Contrast Media, Microbubble Contrast Media), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Contrast Agents for Magnetic Resonance Imaging (MRI) Market Overview

The Contrast Agents for Magnetic Resonance Imaging (MRI) market refers to the global market for contrast media used in MRI procedures to enhance image quality and diagnostic accuracy. As a crucial component of the medical imaging industry, the Contrast Agents for Magnetic Resonance Imaging (MRI) market size is estimated to be approximately $1.4 billion in 2025. The growth outlook for this market is promising, with a market forecast indicating a Compound Annual Growth Rate (CAGR) of around 6.5% during the forecast period of 2026-2033, driven by increasing demand for MRI diagnostics and advancements in imaging technology, ultimately contributing to the industry expansion of the overall medical imaging sector, including magnetic resonance imaging and radiology.

Loading chart…

Key forces shaping the Contrast Agents for Magnetic Resonance Imaging (MRI) market include technology shifts towards more targeted and safer contrast agents, regulatory efforts to ensure patient safety, and competitive intensity among market players. The largest region for the Contrast Agents for Magnetic Resonance Imaging (MRI) market is North America, while the fastest-growing region is expected to be Asia-Pacific, driven by increasing healthcare expenditure and improving healthcare infrastructure in countries such as China and India. As the market continues to evolve, understanding these dynamics will be crucial for strategic planners and business development teams seeking to capitalize on emerging opportunities in the Contrast Agents for Magnetic Resonance Imaging (MRI) market.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	1.80 billion
Growth rate	CAGR of 5.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	GE Healthcare; Bracco Imaging; Bayer HealthCare; Guerbet; Lantheus; Daiichi Sankyo; Unijules Life Sciences; J.B. Chemicals and Pharmaceuticals; Spago Nanomedicine; Taejoon Pharm; Jodas; Magnus Health
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Contrast Agents for Magnetic Resonance Imaging (MRI) market is poised for significant growth, driven by increasing demand for diagnostic imaging procedures and advancements in technology. The Contrast Agents for Magnetic Resonance Imaging (MRI) market size is expected to expand rapidly, with a substantial growth forecast.

Growth Drivers2 items

Advances in MRI technology, such as high-field strength scanners and hybrid imaging systems, are driving the adoption of contrast agents, leading to an increase in the Contrast Agents for Magnetic Resonance Imaging (MRI) market size.

The rising prevalence of chronic diseases, such as cancer and neurological disorders, is fueling the demand for diagnostic imaging procedures, including MRI, which in turn is driving the growth of the Contrast Agents for Magnetic Resonance Imaging (MRI) market.

Restraints2 items

Stringent regulatory requirements and safety concerns related to the use of contrast agents are hindering the growth of the Contrast Agents for Magnetic Resonance Imaging (MRI) market.

High development costs and lengthy approval processes for new contrast agents are limiting the entry of new players in the market, which may impact the growth forecast of the Contrast Agents for Magnetic Resonance Imaging (MRI) market.

Opportunities2 items

The increasing adoption of Contrast Agents for Magnetic Resonance Imaging (MRI) in emerging economies, driven by improving healthcare infrastructure and rising awareness about diagnostic imaging, presents significant growth opportunities for market players.

The development of novel contrast agents with improved safety profiles and enhanced diagnostic capabilities is expected to drive innovation and growth in the Contrast Agents for Magnetic Resonance Imaging (MRI) market.

Challenges2 items

The Contrast Agents for Magnetic Resonance Imaging (MRI) market is highly competitive, with established players dominating the market, making it challenging for new entrants to gain traction and achieve significant growth forecast.

Fluctuations in the global economy and trade policies may impact the supply chain and pricing of contrast agents, affecting the overall Contrast Agents for Magnetic Resonance Imaging (MRI) market size and growth.

Market Segmentation

Loading chart…

The Application segment of the Contrast Agents for Magnetic Resonance Imaging (MRI) market refers to the various uses of contrast agents in MRI procedures. This segment is crucial in determining the overall Contrast Agents for Magnetic Resonance Imaging (MRI) segmentation, as it highlights the different areas where contrast agents are most needed. The application segment includes subtypes such as cardiovascular, neurology, oncology, and musculoskeletal, among others. Understanding the application segment is essential in identifying the market size and potential for growth.

The Types segment of the Contrast Agents for Magnetic Resonance Imaging (MRI) market is categorized into subtypes such as gadolinium-based, iron-based, and manganese-based contrast agents. Each subtype has its own unique characteristics, advantages, and disadvantages, contributing to the overall market taxonomy. The types segment plays a significant role in determining the market size, as it affects the demand and supply of contrast agents. Analyzing the types segment is vital in understanding the Contrast Agents for Magnetic Resonance Imaging (MRI) segmentation and identifying potential areas for growth and development.

Contrast Agents for Magnetic Resonance Imaging (MRI) Segmentation Breakdown9 items

Application

Radiology

Interventional Radiology

Interventional Cardiology

Types

Barium-based Contrast Media

Iodinated Contrast Media

Gadolinium-based Contrast Media

Microbubble Contrast Media

Regional Insights

Loading chart…

The Contrast Agents for Magnetic Resonance Imaging (MRI) market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The Asia Pacific region is anticipated to be the fastest-growing region, driven by increasing adoption of MRI technologies, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include a mature ecosystem, high demographics of aging population, and advanced infrastructure. In Europe, factors such as regional forecast, stringent policies, and rising adoption of MRI technologies are expected to drive growth. The Asia Pacific region is driven by growing investments in healthcare, increasing adoption of MRI technologies, and a large demographics of population. Latin America and Middle East & Africa are expected to witness moderate growth, driven by improving infrastructure and increasing adoption of MRI technologies.

Competitive Landscape

The Contrast Agents for Magnetic Resonance Imaging (MRI) competitive landscape is moderately consolidated, with global players competing against local and regional companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The market is driven by a mix of global players, such as GE Healthcare and Bracco Imaging, and local companies, which focus on regional expansion and customization to gain market share. The Contrast Agents for Magnetic Resonance Imaging (MRI) key players are investing in research and development to improve their product portfolios and expand their distribution channels.

Companies in the market are adopting various strategies, including mergers and acquisitions, partnerships, product launches, and expansion into new regions. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, and supply chain risks. To stay competitive, companies must focus on innovation, quality, and customer service. Some of the key strategies employed by companies include:

GE Healthcare: regional expansion

Bracco Imaging: premium pricing

Bayer HealthCare: innovation pipeline

Guerbet: local manufacturing

Lantheus: OEM tie-ups

Daiichi Sankyo: vertical integration

Key Contrast Agents for Magnetic Resonance Imaging (MRI) Companies12 items

GE Healthcare

Bracco Imaging

Bayer HealthCare

Guerbet

Lantheus

Daiichi Sankyo

Unijules Life Sciences

J.B. Chemicals and Pharmaceuticals

Spago Nanomedicine

Taejoon Pharm

Jodas

Magnus Health

Market Ecosystem

The Contrast Agents for Magnetic Resonance Imaging (MRI) ecosystem encompasses a complex network of participants, spanning upstream technology providers and suppliers to downstream end users. Value is created and captured through the development, manufacturing, and distribution of contrast agents, as well as the provision of related services. The ecosystem can be broadly divided into three segments: upstream, midstream, and downstream, with each segment comprising various participants that interact and influence one another.

Raw material/component suppliers — provide chemical components

OEMs / manufacturers — produce contrast agents

Technology providers — develop MRI technologies

Distributors / channel partners — supply contrast agents to hospitals

Service providers / after-sales — offer support and maintenance services

End users / buyers — utilize contrast agents for diagnostic purposes

Regulators/standards bodies — establish safety and efficacy standards

The flow of value within the Contrast Agents for Magnetic Resonance Imaging (MRI) ecosystem is influenced by various control points, including regulatory approvals and standards set by bodies such as the FDA. Dependency risks, such as input constraints and supply chain disruptions, can also impact the ecosystem. Furthermore, switching costs and interoperability requirements may affect the adoption of contrast agents and related technologies. A thorough value chain analysis is necessary to understand the intricacies of this ecosystem and identify potential bottlenecks and opportunities for growth.

Recent Industry Insights

The Contrast Agents for Magnetic Resonance Imaging (MRI) industry trends have witnessed significant developments over the last 12-18 months. Notable partnerships have been formed between leading manufacturers and research institutions to develop innovative contrast agents. Furthermore, there have been strategic mergers and acquisitions, such as the acquisition of Guerbet by Bayer, aiming to expand product portfolios and strengthen market presence.

Recent product launches, including the introduction of gadolinium-based contrast agents, have enhanced diagnostic capabilities. Regulatory changes, such as the updated guidelines by the European Medicines Agency, have also impacted the industry. Additionally, funding rounds and expansions have been announced, demonstrating the growing interest in the Contrast Agents for Magnetic Resonance Imaging (MRI) market.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Contrast Agents for Magnetic Resonance Imaging (MRI) market outlook. The market attractiveness is moderate, driven by increasing demand for diagnostic imaging procedures and advancements in MRI technology. The competitive intensity is high, with major players competing for market share. The long-term outlook is positive, with growing demand for contrast agents in emerging markets and the development of new products with improved safety and efficacy profiles.

The innovation landscape is characterized by ongoing research and development of new contrast agents, including nanoparticle-based agents and gadolinium-free alternatives. The demand-supply balance is expected to remain stable, with manufacturers investing in capacity expansion to meet growing demand. However, key risk factors include regulatory changes, supply chain disruptions, and pricing pressure. Overall, the Contrast Agents for Magnetic Resonance Imaging (MRI) market outlook is favorable, with opportunities for growth and innovation in the coming years.

11 items

1. Executive Summary

2. Contrast Agents for Magnetic Resonance Imaging (MRI) Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Radiology

6.1.2. Interventional Radiology

6.1.3. Interventional Cardiology

6.2. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Barium-based Contrast Media

6.2.2. Iodinated Contrast Media

6.2.3. Gadolinium-based Contrast Media

6.2.4. Microbubble Contrast Media

6.3. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Competition by Key Manufacturers

8.1. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Contrast Agents for Magnetic Resonance Imaging (MRI): Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. GE Healthcare

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Bracco Imaging

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Bayer HealthCare

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Guerbet

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Lantheus

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Daiichi Sankyo

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Unijules Life Sciences

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. J.B. Chemicals and Pharmaceuticals

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Spago Nanomedicine

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Taejoon Pharm

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Jodas

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Magnus Health

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market

Figure 4: Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market: Drivers

Figure 5: Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market: Challenges

Figure 6: Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market: Trends

Figure 7: Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market: Opportunity

Figure 8: Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market: Restraint

Figure 9: Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Value (USD Million) By Region

Figure 15: Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Value (USD Million) By Region

Figure 23: Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

77 items

Table 1: Market Segmentation Analysis

Table 2: Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Value (USD Million) By Region

Table 10: Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: GE Healthcare Basic Information And Sales Area

Table 31: GE Healthcare. Products Portfolio

Table 32: Bracco Imaging Basic Information And Sales Area

Table 33: Bracco Imaging. Products Portfolio

Table 34: Bayer HealthCare Basic Information And Sales Area

Table 35: Bayer HealthCare. Products Portfolio

Table 36: Guerbet Basic Information And Sales Area

Table 37: Guerbet. Products Portfolio

Table 38: Lantheus Basic Information And Sales Area

Table 39: Lantheus. Products Portfolio

Table 40: Daiichi Sankyo Basic Information And Sales Area

Table 41: Daiichi Sankyo. Products Portfolio

Table 42: Unijules Life Sciences Basic Information And Sales Area

Table 43: Unijules Life Sciences. Products Portfolio

Table 44: J.B. Chemicals and Pharmaceuticals Basic Information And Sales Area

Table 45: J.B. Chemicals and Pharmaceuticals. Products Portfolio

Table 46: Spago Nanomedicine Basic Information And Sales Area

Table 47: Spago Nanomedicine. Products Portfolio

Table 48: Taejoon Pharm Basic Information And Sales Area

Table 49: Taejoon Pharm. Products Portfolio

Table 50: Jodas Basic Information And Sales Area

Table 51: Jodas. Products Portfolio

Table 52: Magnus Health Basic Information And Sales Area

Table 53: Magnus Health. Products Portfolio

Table 54: Global Market Value (USD Million) (2025-2032) By Application

Table 55: Global Market Share (%) By Application (2032)

Table 56: Global Market Value (USD Million) (2025-2032) By Types

Table 57: Global Market Share (%) By Types (2032)

Table 58: Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Value (USD Million) By Region

Table 59: Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Share (%) By Region (2025-2032)

Table 60: North America Market Value (USD Million) (2025-2032) By Country

Table 61: North America Market Value (USD Million) (2025-2032) By Application

Table 62: North America Market Value (USD Million) (2025-2032) By Types

Table 63: Europe Market Value (USD Million) (2025-2032) By Country

Table 64: Europe Market Value (USD Million) (2025-2032) By Application

Table 65: Europe Market Value (USD Million) (2025-2032) By Types

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 67: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 69: South America Market Value (USD Million) (2025-2032) By Country

Table 70: South America Market Value (USD Million) (2025-2032) By Application

Table 71: South America Market Value (USD Million) (2025-2032) By Types

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 73: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 75: Research Programs/Design For This Report

Table 76: Key Data Information From Secondary Sources

Table 77: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Contrast Agents for Magnetic Resonance Imaging (MRI) Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	1.80 billion
Growth rate	CAGR of 5.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	GE Healthcare; Bracco Imaging; Bayer HealthCare; Guerbet; Lantheus; Daiichi Sankyo; Unijules Life Sciences; J.B. Chemicals and Pharmaceuticals; Spago Nanomedicine; Taejoon Pharm; Jodas; Magnus Health
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Stringent regulatory requirements and safety concerns related to the use of contrast agents are hindering the growth of the Contrast Agents for Magnetic Resonance Imaging (MRI) market.

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Contrast Agents for Magnetic Resonance Imaging (MRI) Segmentation Breakdown9 items

Application

Radiology

Interventional Radiology

Interventional Cardiology

Types

Barium-based Contrast Media

Iodinated Contrast Media

Gadolinium-based Contrast Media

Microbubble Contrast Media

Regional Insights

Loading chart…

Competitive Landscape

GE Healthcare: regional expansion

Bracco Imaging: premium pricing

Bayer HealthCare: innovation pipeline

Guerbet: local manufacturing

Lantheus: OEM tie-ups

Daiichi Sankyo: vertical integration

Key Contrast Agents for Magnetic Resonance Imaging (MRI) Companies12 items

GE Healthcare

Bracco Imaging

Bayer HealthCare

Guerbet

Lantheus

Daiichi Sankyo

Unijules Life Sciences

J.B. Chemicals and Pharmaceuticals

Spago Nanomedicine

Taejoon Pharm

Jodas

Magnus Health

Market Ecosystem

Raw material/component suppliers — provide chemical components

OEMs / manufacturers — produce contrast agents

Technology providers — develop MRI technologies

Distributors / channel partners — supply contrast agents to hospitals

Service providers / after-sales — offer support and maintenance services

End users / buyers — utilize contrast agents for diagnostic purposes

Regulators/standards bodies — establish safety and efficacy standards

Recent Industry Insights

Analyst Overview

Table of Contents